Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2034

Annual patent cliff calendar for 2034 — US pharmaceutical patents by expiration date.

Patents
1,452

Quick answer

1,452 indexed pharmaceutical patents have expiration dates in 2034. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8715968

    Methods and reagents for modulating cholesterol levels

    Xenon Pharmaceuticals Inc. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8716017

    Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells

    San Diego Regenerative Medicine Institute · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8716030

    Means for the inhibition of anti-β1-adrenergic receptor antibodies

    Julius-Maximillians-Universitat Wurzburg, A Germany University · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8716301

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8716313

    Crystalline forms of a biphenyl compound

    Theravance, Inc. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8716215

    Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8716279

    Pharmaceutical compositions of clonazepam and method of use thereof

    Jazz Pharmaceuticals, Inc. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8716246

    Azuvirin peptides

    The Regents of the University of California · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8716473

    Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase

    SENTINEL ONCOLOGY LIMITED · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8716287

    Pharmaceutical compounds

    SENTINEL ONCOLOGY LIMITED · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8716315

    Analogs of thalidomide as potential angiogenesis inhibitors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8716320

    Antibacteriall heterocyclic ureas

    Replidyne, Inc. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8716480

    7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

    Addex Pharma, S.A. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8716460

    Pseudomonas AVR and HOP proteins, their encoding nucleic acids, and use thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8716343

    Calixarene-based peptide conformation mimetics, methods of use, and methods of making

    Regents of the University of Minnesota · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8716294

    Methods for treating inflammatory conditions

    Melior Discovery, Inc. · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8722895

    Prolyl hydroxylase inhibitors and method of use

    Akebia Therapeutics, Inc. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8722884

    Pyrimidine derivatives for the treatment of abnormal cell growth

    VERASTEM, INC. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8722889

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8722077

    Drug delivery coating for use with a stent

    ATRIUM MEDICAL CORPORATION · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8722667

    Compositions and methods for inhibiting the proliferation of cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8722616

    Anti-HIV peptides and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8722084

    Controlled release preparation

    Takeda Pharmaceutical Company Limited · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8722032

    Thiol-selective water-soluble polymer derivatives

    Nektar Therapeutics · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8722132

    Application of a coating on a medical device

    ATRIUM MEDICAL CORPORATION · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8722082

    Lipids and compositions for the delivery of therapeutics

    Tekmira Pharmaceuticals Corporation · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8722645

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8722646

    High concentration chitosan-nucleic acid polyplex compositions

    ENGENE, INC. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8722046

    Human monoclonal antibodies protective against bubonic plague

    The United States of America as represented by the Secretary of the Army · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8722628

    Autophagy-inducing peptide

    The Board of Regents of the University of Texas System · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8722653

    Method for treating uterine fibroids

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8722732

    Oligomer-calcimimetic conjugates and related compounds

    Nektar Therapeutics · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8722704

    Modulators of ATP-binding cassette-transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8721620

    Swallowable drug delivery device and methods of drug delivery

    Rani Therapeutics, LLC · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8722716

    Isoxazole treatments for diabetes

    The Board of Regents of the University of Texas System · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8722063

    Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8722660

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8722662

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8722722

    Raltegravir salts and crystalline forms thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8722738

    Acetycysteine compositions and methods of use thereof

    Cumberland Pharmaceuticals Inc. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8722894

    1,3-disubstituted-4-phenyl-1H-pyridin-2-ones

    Addex Pharma, S.A. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8722871

    VMP-like sequences of pathogenic borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8725266

    Method for stimulating retinal response using photoactive devices

    The Regents of the University of Colorado, a Body Corporate · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8722708

    Substituted isoindolines as aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8722863

    Solid state forms of fidaxomycin and processes for preparation thereof

    Teva Pharmaceutical Works Ltd. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8722939

    Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

    Northwestern University · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8722896

    Prokineticin receptor antagonists and uses thereof

    The Regents of the University of California · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8729088

    Toll-like receptor modulators and treatment of diseases

    The Regents of the University of California · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2034?

1,452 published patents in our USPTO index have expiration dates falling in calendar year 2034.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.